Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.51 USD | +0.45% | -3.84% | +70.19% |
08/05 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
07/05 | Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+70.19% | 25Cr | |
+29.77% | 4.92TCr | |
+1.00% | 4.21TCr | |
+50.47% | 4.04TCr | |
-5.26% | 2.89TCr | |
+13.68% | 2.61TCr | |
-22.99% | 1.87TCr | |
+8.22% | 1.33TCr | |
+32.41% | 1.23TCr | |
-1.62% | 1.2TCr |
- Stock Market
- Equities
- DSGN Stock
- News Design Therapeutics, Inc.
- Wedbush Downgrades Design Therapeutics to Neutral From Outperform, Pushes Back DT-216 Launch Timing; Cuts PT to $6 From $19